Enkephalinase inhibitors: potential agents for the management of pain.

  title={Enkephalinase inhibitors: potential agents for the management of pain.},
  author={V. Thanawala and V. Kadam and R. Ghosh},
  journal={Current drug targets},
  volume={9 10},
  • V. Thanawala, V. Kadam, R. Ghosh
  • Published 2008
  • Medicine, Chemistry
  • Current drug targets
  • Management of acute and chronic pain has always been a key area of clinical research. Enkephalinase inhibitors (EIs) seem to be promising as therapeutic agents having antinociceptive action. They additionally possess anticraving, antidiarrhoeal and antidepressant actions. The antinociceptive action of EIs has been reported for over a decade however, their therapeutic potential is yet to be effectively explored. EIs may be broadly classified as endogenous and those that are obtained… CONTINUE READING
    64 Citations
    Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?
    • 7
    • PDF
    NESS002ie: A new fluorinated thiol endopeptidase inhibitor with antinociceptive activity in an animal model of persistent pain
    • 3
    Novel Analgesics with Peripheral Targets
    • 1
    • PDF